Leiden University Medical Center-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2024

  1. A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma

    eBioMedicine, Vol. 102